332 related articles for article (PubMed ID: 11940053)
21. Low level of glucocorticoid receptor messenger ribonucleic acid in pituitary adenomas manifesting Cushing's disease with resistance to a high dose-dexamethasone suppression test.
Mu YM; Takayanagi R; Imasaki K; Ohe K; Ikuyama S; Yanase T; Nawata H
Clin Endocrinol (Oxf); 1998 Sep; 49(3):301-6. PubMed ID: 9861319
[TBL] [Abstract][Full Text] [Related]
22. Cushing's disease due to plurihormonal adrenocorticotropic hormone and gonadotropin-producing pituitary adenoma.
Egensperger R; Scheithauer BW; Horvath E; Kovacs K; Giannini C; Young WF; Lloyd R; Atkinson J; Nippoldt TB
Acta Neuropathol; 2001 Oct; 102(4):398-403. PubMed ID: 11603817
[TBL] [Abstract][Full Text] [Related]
23. Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.
Giustina A; Bossoni S; Bussi AR; Pozzi A; Wehrenberg WB
Endocr Res; 1993 Mar; 19(1):47-56. PubMed ID: 7681769
[TBL] [Abstract][Full Text] [Related]
24. An immunoperoxidase study of a human pituitary adenoma associated with Cushing's syndrome.
Wowra B; Peiffer J
Pathol Res Pract; 1984 Mar; 178(4):349-54. PubMed ID: 6328462
[TBL] [Abstract][Full Text] [Related]
25. Galectin-3 Expression in Functioning and Silent ACTH-Producing Adenomas.
Jin L; Riss D; Ruebel K; Kajita S; Scheithauer BW; Horvath E; Kovacs K; Lloyd RV
Endocr Pathol; 2005; 16(2):107-14. PubMed ID: 16199895
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of the growth hormone and type 1 insulin-like growth factor receptors in human somatotroph tumours and an analysis of possible mutations of the growth hormone receptor.
Kola B; Korbonits M; Diaz-Cano S; Kaltsas G; Morris DG; Jordan S; Metherell L; Powell M; Czirják S; Arnaldi G; Bustin S; Boscaro M; Mantero F; Grossman AB
Clin Endocrinol (Oxf); 2003 Sep; 59(3):328-38. PubMed ID: 12919156
[TBL] [Abstract][Full Text] [Related]
27. A case of Cushing's disease caused by pituitary adenoma producing adrenocorticotropic hormone and growth hormone concomitantly: aberrant expression of transcription factors NeuroD1 and Pit-1 as a proposed mechanism.
Tahara S; Kurotani R; Ishii Y; Sanno N; Teramoto A; Osamura RY
Mod Pathol; 2002 Oct; 15(10):1102-5. PubMed ID: 12379758
[TBL] [Abstract][Full Text] [Related]
28. Hypergastrinaemia in Cushing's syndrome: pituitary origin or glucocorticoid-induced?
López-Guzmán A; Salvador J; Frutos R; Díez JJ; Iglesias P; Sastre J; G-omez-Pan A
Clin Endocrinol (Oxf); 1996 Mar; 44(3):335-9. PubMed ID: 8729533
[TBL] [Abstract][Full Text] [Related]
29. Comparative evaluation of conventional and dynamic magnetic resonance imaging of the pituitary gland for the diagnosis of Cushing's disease.
Tabarin A; Laurent F; Catargi B; Olivier-Puel F; Lescene R; Berge J; Galli FS; Drouillard J; Roger P; Guerin J
Clin Endocrinol (Oxf); 1998 Sep; 49(3):293-300. PubMed ID: 9861318
[TBL] [Abstract][Full Text] [Related]
30. Treatment of Cushing's disease by transsphenoidal, pituitary microsurgery: prognosis factors and long-term follow-up.
Bakiri F; Tatai S; Aouali R; Semrouni M; Derome P; Chitour F; Benmiloud M
J Endocrinol Invest; 1996 Oct; 19(9):572-80. PubMed ID: 8957739
[TBL] [Abstract][Full Text] [Related]
31. Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess.
Colombo P; Passini E; Re T; Faglia G; Ambrosi B
Clin Endocrinol (Oxf); 1997 Jun; 46(6):661-8. PubMed ID: 9274696
[TBL] [Abstract][Full Text] [Related]
32. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
[TBL] [Abstract][Full Text] [Related]
33. Repeat transsphenoidal surgery for Cushing's disease.
Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
[TBL] [Abstract][Full Text] [Related]
34. Identification of adrenocorticotropin receptor messenger ribonucleic acid in the human pituitary and its loss of expression in pituitary adenomas.
Morris DG; Kola B; Borboli N; Kaltsas GA; Gueorguiev M; McNicol AM; Ferrier R; Jones TH; Baldeweg S; Powell M; Czirják S; Hanzély Z; Johansson JO; Korbonits M; Grossman AB
J Clin Endocrinol Metab; 2003 Dec; 88(12):6080-7. PubMed ID: 14671214
[TBL] [Abstract][Full Text] [Related]
35. Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.
Korbonits M; Jacobs RA; Aylwin SJ; Burrin JM; Dahia PL; Monson JP; Honegger J; Fahlbush R; Trainer PJ; Chew SL; Besser GM; Grossman AB
J Clin Endocrinol Metab; 1998 Oct; 83(10):3624-30. PubMed ID: 9768675
[TBL] [Abstract][Full Text] [Related]
36. Supra- and extrasellar pituitary microadenoma as a cause of Cushing's disease.
Murakami N; Furuto-Kato S; Fujisawa I; Ohyama K; Nakao S; Kuwayama A; Kageyama N
Endocr J; 1998 Oct; 45(5):631-6. PubMed ID: 10395243
[TBL] [Abstract][Full Text] [Related]
37. [Corticotroph adenoma].
Guignat L; Assie G; Bertagna X; Bertherat J
Presse Med; 2009 Jan; 38(1):125-32. PubMed ID: 19041214
[TBL] [Abstract][Full Text] [Related]
38. The value of inferior petrosal sinus sampling in diagnosis and treatment of Cushing's disease.
Landolt AM; Schubiger O; Maurer R; Girard J
Clin Endocrinol (Oxf); 1994 Apr; 40(4):485-92. PubMed ID: 8187314
[TBL] [Abstract][Full Text] [Related]
39. Presence of neurophysins in the human pituitary corticotrophs, Cushing's adenomas, and growth hormone-producing adenomas detected by immunohistochemical study.
Kimura N; Andoh N; Sasano N; Sasaki A; Mouri T
Am J Pathol; 1986 Nov; 125(2):269-75. PubMed ID: 3024492
[TBL] [Abstract][Full Text] [Related]
40. Transsphenoidal surgery for Cushing's disease: does what is removed determine the endocrine outcome?
Burke CW; Adams CB; Esiri MM; Morris C; Bevan JS
Clin Endocrinol (Oxf); 1990 Oct; 33(4):525-37. PubMed ID: 2171817
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
